Splenectomy in lymphoproliferative disorders

Basit Öğe Kaydı
dc.contributor.authorAltintaş A.
dc.contributor.authorÇil T.
dc.contributor.authorAyyildiz O.
dc.date.accessioned2024-04-24T18:43:38Z
dc.date.available2024-04-24T18:43:38Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description.abstractSplenomegaly is common in the course of lymphoproliferative disorders. Massive splenomegaly sometimes leads to bulk symptoms and cytopenias. Splenomegaly may also be the primary manifestation of lymphoproliferative disorders. Splenectomy, with an acceptable surgical risk, has the potential to establish the diagnosis of lymphoproliferative disorders in patient with splenomegaly without lymphadenopathy and negative bone marrow findings. Splenectomy in these group patients is performed for either diagnostic or therapeutic reasons. Splenectomy has the potential to relieve bulk symptoms, correct cytopenias, and facilitate aggressive chemotherapy.en_US
dc.identifier.endpage218en_US
dc.identifier.issn1306-133X
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-33845914886en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage211en_US
dc.identifier.urihttps://hdl.handle.net/11468/24244
dc.identifier.volume16en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofUHOD - Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectLymphomaen_US
dc.subjectSplenectomyen_US
dc.subjectSplenectomy İn Lymphoproliferative Disordersen_US
dc.titleSplenectomy in lymphoproliferative disordersen_US
dc.title.alternativeLenfoproliferatif hastaliklarda splenektomien_US
dc.typeReview Articleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu